BSE filing, NSE: SAURASHCEM. Summary written from the filing by ALFA Finder's alert engine.
Saurashtra Cements Ltd: key numbers
- Share price
- ₹47.33
- Market cap
- ₹526.7 Cr
- Revenue (annual)
- ₹1,666 Cr
- Net profit (annual)
- ₹14.42 Cr
- P/E (TTM)
- 78.7×Sector 32.4×
- Promoter holding
- 66.62%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Saurashtra Cements Ltd
All →Saurashtra Cements Board Meeting Date
Saurashtra Cement Ltd will hold a board meeting on 4th November 2026 to consider and approve its unaudited financial results for the quarter ended September 2026.
Saurashtra Cements Other Announcement
The company filed its quarterly shareholding pattern for the period ended September 30, 2026, in compliance with SEBI Regulation 31.
Saurashtra Cements Management Change
Saurashtra Cement Ltd appointed Mr. Anurag Tiwari as Managing Director-Designate, effective 16th October 2026. This appointment is classified under Senior Management Personnel.
Saurashtra Cements Legal & Regulatory
Saurashtra Cement received a GST show cause notice from the Deputy Commissioner of State Tax demanding ₹3.83 Crore, which the company intends to contest.
- Value
- ₹3.83 Cr
Saurashtra Cements Credit Rating
ICRA Limited has reaffirmed the credit rating of [ICRA] BBB- (Stable) for bank facilities of Saurashtra Cement Limited aggregating to ₹404 Crore.
Saurashtra Cements Business Update
Saurashtra Cement signed a Power Consumption Agreement and Share Purchase Agreement with Jamnagar Renewables Two Private Limited, acquiring an 8.86% stake for Rs 14.92 Crore.
- Value
- ₹14.92 Cr
- From
- Jamnagar Renewables Two Private Limited
- Execution
- 25 years
- Wind-Solar Hybrid power
- 14.0 MW
Other regulatory approval announcements
All →John Cockerill India Regulatory Approval
John Cockerill India received Reserve Bank of India approval for acquiring shares of John Cockerill Metals International SA. This allows the company to proceed with the share-swap acquisition.
Gland Pharma Regulatory Approval
Gland Pharma received USFDA approval for Methylprednisolone Acetate Injectable Suspension USP in multiple vial formats. The product is bioequivalent to Pfizer's Depo-Medrol in a ~$214M US market.
City Union Bank Regulatory Approval
City Union Bank disclosed RBI approval for appointing Shri Sankaran G as Executive Director (Whole-time Director) for three years. The board appointment and formal disclosures will follow later.
- Execution
- Three years from the date of taking charge
Lupin Regulatory Approval
Lupin received US FDA approval for its generic Amifampridine Tablets 10 mg ANDA. As a first-to-file applicant, it is eligible for 180-day shared generic exclusivity.
Som Distilleries & Breweries Regulatory Approval
Som Distilleries received manufacturing licences for its Bhopal plant from the Madhya Pradesh Excise Department, plus product label and rate approvals. Manufacturing and sales are expected to resume soon.
AGI Infra Regulatory Approval
Agi Infra received RERA registration PBRERA-SAS80-PR1452-102026 from Punjab RERA for its Utopia by AGI group housing project in New Chandigarh. The registration is valid until 30 March 2031.
- Execution
- Valid up to March 30, 2031